Status
Conditions
Treatments
About
The NUCaCD study aims to develop a reliable registry of patients suffering inflammatory bowel diseases in the Republic of Kazakhstan.
Full description
The NUCaCD aims to study the prevalence of inflammatory bowel diseases in the Republic of Kazakhstan and create a reliable database, which will greatly facilitate future planning of the volume of health resources needed to address these diseases management and will help to optimize preventive measures and will support future research to better understand the etiology, new options treatment and factors affecting prognosis, relapses, development of complications and quality of life.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
2,000 participants in 1 patient group
Loading...
Central trial contact
Kanat Khazhidinov, M.Sc.; Jamilya Kaibullayeva, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal